Spruce Biosciences, Inc. (SPRB)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-13) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-09) · 99.1 | 8-K (2026-01-08) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-10) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-14) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-06) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-04-15) · 99.1 · 99.2 | 8-K (2025-04-01) | ||
| 10-Q | Q3-2024 | 8-K (2024-11-12) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-12) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-13) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-13) · 99.1 | 8-K (2024-01-08) · 99.1 · 99.2 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-13) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-14) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Balance Sheets | ||
| Balance Sheets (P) | ||
| Statements of Operations and Comprehensive Loss | ||
| Statements of Stockholders' Equity | ||
| Statements of Cash Flows | ||
| Statements of Stockholders' Equity (P) | ||
| Notes | ||
| 401(k) Retirement Savings Plan | — |
|
| Balance Sheet Components | ||
| Capital Structure | ||
| Collaboration and License Agreements | — |
|
| Commitments and Contingencies | ||
| Cybersecurity Risk Management, Strategy and Governance | — |
|
| Debt | — |
|
| Fair Value Measurements | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | ||
| License Agreements | ||
| License and Purchase Agreements | ||
| Net Loss Per Share | ||
| Organization and Principal Activities | ||
| Pay Vs Performance Disclosure | ||
| Related Party Transactions | ||
| Stock-based Compensation | — |
|
| Stock-based Compensation Expense | — |
|
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||
| Svb Term Loan | — |
|
| Term Loan | ||